Igc Pharma, Inc. (IGC) — DEF 14A Filings

All DEF 14A filings from Igc Pharma, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

  • IGC Pharma Files Definitive Proxy Statement — Aug 18, 2025 Risk: medium
    IGC Pharma, Inc. filed its definitive proxy statement on August 18, 2025, for the fiscal year ending March 31, 2025. The company, previously known as India Glob
  • IGC Pharma Files 2024 Proxy Statement — Jul 8, 2024 Risk: low
    IGC Pharma, Inc. (IGC) filed a Definitive Proxy Statement (DEF 14A) on July 8, 2024, for its fiscal year ending March 31, 2024. The filing concerns the company'

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.